We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NFGC
11676
CALL
New Found Gold
NFGC
$649M
$49.6K ﹤0.01%
11,900
-11,700
-50% -$52.9K
BCPC
11677
PUT
Balchem Corp
BCPC
$5.69B
$49.6K ﹤0.01%
400
+200
+100% +$26.6K
VYGR icon
11678
CALL
Voyager Therapeutics
VYGR
$201M
$49.6K ﹤0.01%
6,400
-9,500
-60% -$86.7K
GGR icon
11679
CALL
Gogoro
GGR
$45.8M
$49.5K ﹤0.01%
945
-285
-23% -$17.3K
NRIX icon
11680
CALL
Nurix Therapeutics
NRIX
$2.81B
$49.5K ﹤0.01%
6,300
-118,600
-95% -$1.08M
OPFI icon
11681
PUT
OppFi
OPFI
$610M
$49.4K ﹤0.01%
19,600
+18,800
+2,350% +$43.8K
CALT
11682
CALL
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$49.3K ﹤0.01%
2,700
-2,900
-52% -$50.2K
CMCL icon
11683
CALL
Caledonia Mining Corp
CMCL
$434M
$49.3K ﹤0.01%
5,000
-1,000
-17% -$11.1K
FCUV icon
11684
Focus Universal
FCUV
$3.95M
$49.3K ﹤0.01%
63
-34
-35% -$24.2K
SFNC icon
11685
PUT
Simmons First National
SFNC
$3.48B
$49.2K ﹤0.01%
2,900
-1,000
-26% -$18K
DMC
11686
PUT
Del Monte Corp
DMC
$1.43B
$49.1K ﹤0.01%
1,900
-200
-10% -$5.23K
CONN
11687
PUT
DELISTED
Conn's Inc.
CONN
$49K ﹤0.01%
12,400
-6,800
-35% -$28.2K
FDIS icon
11688
PUT
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.72B
$48.9K ﹤0.01%
+700
New +$51.4K
CPK icon
11689
PUT
Chesapeake Utilities
CPK
$3.26B
$48.9K ﹤0.01%
500
+400
+400% +$45.3K
ULBI icon
11690
PUT
Ultralife
ULBI
$125M
$48.8K ﹤0.01%
5,000
+4,000
+400% +$32K
COGT icon
11691
PUT
Cogent Biosciences
COGT
$6.58B
$48.8K ﹤0.01%
5,000
+4,100
+456% +$48.6K
APTO
11692
DELISTED
Aptose Biosciences, Inc.
APTO
$48.6K ﹤0.01%
+578
New +$68.1K
PTF icon
11693
PUT
Invesco Dorsey Wright Technology Momentum ETF
PTF
$676M
$48.6K ﹤0.01%
1,100
-2,200
-67% -$105K
BETR icon
11694
Better Home & Finance Holding
BETR
$261M
$48.4K ﹤0.01%
+2,037
New +$1.56M
WHWK
11695
CALL
Whitehawk Therapeutics
WHWK
$254M
$48.4K ﹤0.01%
10,000
-31,500
-76% -$183K
TMBR
11696
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$48.4K ﹤0.01%
16,260
-16,925
-51% -$39.4K
PAYS icon
11697
CALL
Paysign
PAYS
$744M
$48.4K ﹤0.01%
24,800
+14,700
+146% +$30.3K
DLNG icon
11698
Dynagas LNG Partners
DLNG
$140M
$48.3K ﹤0.01%
17,836
-9,700
-35% -$26.8K
MNTK icon
11699
CALL
Montauk Renewables
MNTK
$268M
$48.3K ﹤0.01%
5,300
+3,600
+212% +$32.3K
HTBK
11700
CALL
DELISTED
Heritage Commerce
HTBK
$48.3K ﹤0.01%
5,700
+2,000
+54% +$17.8K
466 467
468
469 470

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.